New drug in phase 3 clinical trials to treat NASH
A drug is now in phase three clinical trials to treat non-alcoholic steatohepatitis (NASH). Dr. Pradeep Kumar, from Austin Gastroenterology, joins us to talk more about what this means.
A drug is now in phase three clinical trials to treat non-alcoholic steatohepatitis (NASH). Dr. Pradeep Kumar, from Austin Gastroenterology, joins us to talk more about what this means.